Sterling, Richard K.

Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection†‡

Sterling, R. K., Lissen, E., Clumeck, N., Sola, R., Correa, M. C., Montaner, J., S. Sulkowski, M., Torriani, F. J., Dieterich, D. T., Thomas, D. L., et al. (2006) · Hepatology

Liver Disease Diagnosis and TreatmentLiver Disease and Transplantation

Cited by 5,021

Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities

Sanyal, A. J., Campbell–Sargent, C., Mirshahi, F., Rizzo, W. B., Contos, M. J., Sterling, R. K., Luketic, V. A., Shiffman, M. L., & Clore, J. N. (2001) · Gastroenterology

Liver Disease Diagnosis and TreatmentAlcohol Consumption and Health Effects

Cited by 2,078

The plasma lipidomic signature of nonalcoholic steatohepatitis

Puri, P., Wiest, M. M., Cheung, O., Mirshahi, F., Sargeant, C., Min, H., Contos, M. J., Sterling, R. K., Fuchs, M., Zhou, H., et al. (2009) · Hepatology

Liver Disease Diagnosis and TreatmentMetabolomics and Mass Spectrometry Studies

Cited by 655

Modulation of the metabiome by rifaximin in patients with cirrhosis and minimal hepatic encephalopathy

Bajaj, J. S., Heuman, D. M., Sanyal, A. J., Hylemon, P. B., Sterling, R. K., Stravitz, R. T., Fuchs, M., Ridlon, J. M., Daita, K., Monteith, P., et al. (2013) · PLoS ONE

Liver Disease and TransplantationGut microbiota and health

Cited by 430

Primary sclerosing cholangitis: evaluation with MR cholangiography-a case-control study

Fulcher, A. S., Turner, M. A., Franklin, K. J., Shiffman, M. L., Sterling, R. K., Luketic, V. A. C., & Sanyal, A. J. (2000) · Radiology

Liver Diseases and ImmunityPediatric Hepatobiliary Diseases and Treatments

Cited by 206

Chronic opioid use is associated with altered gut microbiota and predicts readmissions in patients with cirrhosis

Acharya, C., Betrapally, N. S., Gillevet, P. M., Sterling, R. K., Akbarali, H., White, M. B., Ganapathy, D., Fagan, A., Sikaroodi, M., & Bajaj, J. S. (2017) · Alimentary Pharmacology & Therapeutics

Liver Disease and TransplantationGut microbiota and health

Cited by 175

Enhancement of functional connectivity, working memory and inhibitory control on multi-modal brain MR imaging with rifaximin in cirrhosis: implications for the gut-liver-brain axis

Ahluwalia, V., Wade, J. B., Heuman, D. M., Hammeke, T. A., Sanyal, A. J., Sterling, R. K., Stravitz, R. T., Luketic, V., Siddiqui, M. S., Puri, P., et al. (2014) · Metabolic Brain Disease

Liver Disease and TransplantationAdvanced MRI Techniques and Applications

Cited by 92

PROMIS computerised adaptive tests are dynamic instruments to measure health-related quality of life in patients with cirrhosis: PROMIS tools for quality of life assessment in cirrhosis

Bajaj, J. S., Thacker, L. R., Wade, J. B., Sanyal, A. J., Heuman, D. M., Sterling, R. K., Gibson, D. P., Stravitz, R. T., Puri, P., Fuchs, M., et al. (2011) · Alimentary Pharmacology & Therapeutics

Psychometric Methodologies and TestingLiver Disease and Transplantation

Cited by 83

HCV eradication does not impact gut dysbiosis or systemic inflammation in cirrhotic patients

Bajaj, J. S., Sterling, R. K., Betrapally, N. S., Nixon, D. E., Fuchs, M., Daita, K., Heuman, D. M., Sikaroodi, M., Hylemon, P. B., White, M. B., et al. (2016) · Alimentary Pharmacology & Therapeutics

Gut microbiota and healthHepatitis C virus research

Cited by 63